Rakesh K. Jain, director of the Edwin L. Steele Laboratory for Tumor Biology in the radiation oncology department of Massachusetts General Hospital and Harvard Medical School talks about his article in the February issue of Scientific American about interfering with extracellular matrix as a way to increase the efficacy of cancer therapy.
For information about clinical trials related to the concepts in this article, go to http://clinicaltrials.gov/show/NCT01821729
